Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
about
Factors associated with post-stroke depression and fatigue: lesion location and coping styles.Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population.Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study.Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis.
P2860
Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@en
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@nl
type
label
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@en
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@nl
prefLabel
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@en
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@nl
P2093
P2860
P356
P1433
P1476
Phase II, randomised, double-b ...... eceiving LHRH-agonist therapy.
@en
P2093
Jaimin R Bhatt
Karen M Hersey
Neil E Fleshner
Patrick O Richard
Rehab Chahin
Shabbir M H Alibhai
P2860
P304
P356
10.1111/BJU.12755
P577
2014-03-31T00:00:00Z